FindMyRecallSubscribe
Class III: unlikely to cause harmTerminated

AbbVie Mavik¿ trandolapril tablets 4mg Recall

Mavik¿ trandolapril tablets 4mg, 100 count bottle, Rx only, Manufactured by Halo Pharm…

AbbVie Inc. · North Chicago, IL

Risk level
Class III
Reported by FDA
Aug 28, 2013
Recall ID
D-901-2013
Check your lot numberHow we source this data

Summary

AbbVie recalled Mavik¿ trandolapril tablets 4mg starting Aug 1, 2013. The FDA classified it as Class III (unlikely to cause harm) and published enforcement report D-901-2013 on Aug 28, 2013. Reason: Labeling: Incorrect Package Insert; product packaged with outdated version of the insert. Status: Terminated.

Why it was recalled

Labeling: Incorrect Package Insert; product packaged with outdated version of the insert

Product description

Mavik¿ trandolapril tablets 4mg, 100 count bottle, Rx only, Manufactured by Halo Pharmaceutical Inc., Whippany, NJ for Abbott Laboratories, North Chicago, IL 60064, USA

Lot numbers, UPCs & expiration codes

Lot 22033GY

Where it was sold

Nationwide

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-901-2013
Classification
Class III
Status
Terminated
Recall initiated
Aug 1, 2013
FDA report date
Aug 28, 2013
Quantity
704 bottles
Recall type
Voluntary: Firm initiated
Recalling firm
AbbVie Inc.

Original FDA data

Every field from FDA enforcement report D-901-2013, exactly as published.

Show all FDA fields
City
North Chicago
State
IL
Status
Terminated
Country
United States
Event ID
65851
Address
1401 Sheridan Rd
Code information
Lot 22033GY
Postal code
60064-1803
Report date
Aug 28, 2013
Product type
Drugs
Recall number
D-901-2013
Classification
Class III
Recalling firm
AbbVie Inc.
Product quantity
704 bottles
Termination date
Nov 7, 2013
Reason for recall
Labeling: Incorrect Package Insert; product packaged with outdated version of the insert
Voluntary / mandated
Voluntary: Firm initiated
Product description
Mavik¿ trandolapril tablets 4mg, 100 count bottle, Rx only, Manufactured by Halo Pharmaceutical Inc., Whippany, NJ for Abbott Laboratories, North Chicago, IL 60064, USA
Distribution pattern
Nationwide
Recall initiation date
Aug 1, 2013
Initial firm notification
Letter
Center classification date
Aug 20, 2013

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-901-2013, published Aug 28, 2013. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls